大唐药业
(920433)
| 流通市值：7.94亿 | | | 总市值：12.00亿 |
| 流通股本：1.69亿 | | | 总股本：2.56亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 58,575,608.14 | 42,981,295.49 | 133,403,704.17 | 102,317,249.5 |
| 营业总成本 | 67,318,949.6 | 39,737,876.88 | 213,454,416.1 | 150,712,037.99 |
| 其他经营收益 | | | | |
| 营业利润 | -9,362,136.86 | 2,801,863.36 | -86,278,562.3 | -47,943,695.23 |
| 利润总额 | -9,162,136.86 | 2,801,863.36 | -86,781,628.75 | -47,476,089.27 |
| 净利润 | -7,998,320.21 | 2,389,587.39 | -83,188,081.18 | -41,077,170.17 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | -7,998,320.21 | 2,389,587.39 | -83,188,081.18 | -41,077,170.17 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 118,520,209.78 | 156,118,065.35 | 140,149,409.37 | 163,241,529.41 |
| 非流动资产: | | | | |
| 非流动资产合计 | 390,662,778.56 | 391,576,441.71 | 403,764,465.55 | 418,068,512.09 |
| 资产总计 | 509,182,988.34 | 547,694,507.06 | 543,913,874.92 | 581,310,041.5 |
| 流动负债: | | | | |
| 流动负债合计 | 119,016,243.92 | 148,972,690.12 | 144,502,823.92 | 138,518,464.86 |
| 非流动负债: | | | | |
| 非流动负债合计 | 18,305,078.33 | 19,045,385.32 | 19,551,064.7 | 20,820,679.33 |
| 负债合计 | 137,321,322.25 | 168,018,075.44 | 164,053,888.62 | 159,339,144.19 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 371,861,666.09 | 379,676,431.62 | 379,859,986.3 | 421,970,897.31 |
| 股东权益合计 | 371,861,666.09 | 379,676,431.62 | 379,859,986.3 | 421,970,897.31 |
| 负债和股东权益合计 | 509,182,988.34 | 547,694,507.06 | 543,913,874.92 | 581,310,041.5 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 81,963,680.84 | 34,352,442.22 | 163,207,662.25 | 133,502,751.69 |
| 经营活动现金流出小计 | 68,229,170.36 | 36,388,729.45 | 176,606,230 | 138,916,885.1 |
| 经营活动产生的现金流量净额 | 13,734,510.48 | -2,036,287.23 | -13,398,567.75 | -5,414,133.41 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 20,022,273.99 | - | 163,356,129.07 | 122,162,964.06 |
| 投资活动现金流出小计 | 35,892,313.96 | 631,241.87 | 136,654,749.44 | 112,086,925.58 |
| 投资活动产生的现金流量净额 | -15,870,039.97 | -631,241.87 | 26,701,379.63 | 10,076,038.48 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 44,490,015.54 | 23,450,543.72 | 87,812,653.1 | 67,520,870.93 |
| 筹资活动现金流出小计 | 49,342,477.58 | 10,551,399.83 | 113,326,356.75 | 84,080,663.08 |
| 筹资活动产生的现金流量净额 | -4,852,462.04 | 12,899,143.89 | -25,513,703.65 | -16,559,792.15 |
| 汇率变动对现金及现金等价物的影响 | -1,846.13 | 919.49 | -1,351.87 | -702.15 |
| 现金及现金等价物净增加额 | -6,989,837.66 | 10,232,534.28 | -12,212,243.64 | -11,898,589.23 |
| 期末现金及现金等价物余额 | 12,489,732.18 | 29,712,104.12 | 19,479,569.84 | 19,793,224.25 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -6,989,837.66 | - | -12,212,243.64 | - |